학술논문

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Document Type
article
Source
Proceedings of the National Academy of Sciences of the United States of America. 117(45)
Subject
Biodefense
Emerging Infectious Diseases
Vaccine Related
Infectious Diseases
Pneumonia
Prevention
Lung
Aetiology
2.1 Biological and endogenous factors
Infection
Good Health and Well Being
Active Transport
Cell Nucleus
Animals
Binding Sites
COVID-19
Chlorocebus aethiops
HEK293 Cells
Humans
Interferons
Nuclear Matrix-Associated Proteins
Nuclear Pore
Nuclear Pore Complex Proteins
Nucleocytoplasmic Transport Proteins
Protein Binding
STAT1 Transcription Factor
STAT2 Transcription Factor
Signal Transduction
Vero Cells
Viral Proteins
Immunization
Pneumonia & Influenza
Biotechnology
Development of treatments and therapeutic interventions
5.1 Pharmaceuticals
SARS-CoV-2
interferon signaling antagonism
STATs
ORF6
Nup98
Language
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic that is a serious global health problem. Evasion of IFN-mediated antiviral signaling is a common defense strategy that pathogenic viruses use to replicate and propagate in their host. In this study, we show that SARS-CoV-2 is able to efficiently block STAT1 and STAT2 nuclear translocation in order to impair transcriptional induction of IFN-stimulated genes (ISGs). Our results demonstrate that the viral accessory protein Orf6 exerts this anti-IFN activity. We found that SARS-CoV-2 Orf6 localizes at the nuclear pore complex (NPC) and directly interacts with Nup98-Rae1 via its C-terminal domain to impair docking of cargo-receptor (karyopherin/importin) complex and disrupt nuclear import. In addition, we show that a methionine-to-arginine substitution at residue 58 impairs Orf6 binding to the Nup98-Rae1 complex and abolishes its IFN antagonistic function. All together our data unravel a mechanism of viral antagonism in which a virus hijacks the Nup98-Rae1 complex to overcome the antiviral action of IFN.